VENUSREM — Venus Remedies Balance Sheet
0.000.00%
- IN₹6.04bn
- IN₹4.41bn
- IN₹6.48bn
- 88
- 78
- 96
- 99
Annual balance sheet for Venus Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
| C2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | IAS | IAS | IAS | IAS | IAS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 292 | 458 | 713 | 838 | 1,563 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 608 | 671 | 1,255 | 1,479 | 1,831 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,340 | 2,780 | 3,230 | 3,595 | 4,517 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,901 | 1,782 | 1,628 | 1,544 | 1,511 | 
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,559 | 5,798 | 6,011 | 6,268 | 7,157 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 974 | 927 | 826 | 794 | 1,363 | 
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,556 | 1,394 | 1,407 | 1,393 | 1,548 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 4,003 | 4,404 | 4,603 | 4,876 | 5,609 | 
| Total Liabilities & Shareholders' Equity | 5,559 | 5,798 | 6,011 | 6,268 | 7,157 | 
| Total Common Shares Outstanding |